InnoEnergy on Lisbon leg of Energy Union tour

Written by Fergal Hogan on . Posted in Innovation

Commissioner Maroš Šefčovič meets InnoEnergy’s and its innovators in Portugal, while celebrating the country’s progress and potential as a clean energy leader

InnoEnergy, Europe’s sustainable energy innovation engine, was proud to welcome Commissioner Maroš Šefčovič to Lisbon this week, showcasing the clean-energy contribution of some of the Portuguese innovations it has supported. As a Vice President of the European Commission (EC) and head of the Energy Union, Commissioner Šefčovič was in Portugal as part of his Energy Union Tour, with the aim of seeing first-hand some examples of Portugal’s leadership in clean energy innovation.

Get Automated

Written by Henry Martin on . Posted in Innovation

CEO Insight's Henry Martin caught up with Hans Leybaert, CEO of UnifiedPost, a leading Fintech Company in the international spotlight.

UnifiedPost, founded in 2000, started as a platform for document management and over the years acquired several companies to create the company we are today. We have 200 people working across Europe on a BPaaS platform based on the basic components document, payment, identity and APPs to support our customers with upgrading their business processes. UnifiedPost helps both small and large corporates to focus on what they do best – expanding their business. 

CEO Insight: How did UnifiedPost become a Fintech company?

Hans Leybaert: UnifiedPost started off as a document management company but soon learned that the growing Fintech industry was important to get involved in. Also, payments are very important to offer total document solutions. And since the acquisition of PowertoPay, Onea and Nomadesk we can officially say we are specialised in financial technologies and that we are one of the key players in the market offering a one-stop-shop, from purchase to payment.

Aargau – Scope for Life Sciences Innovations

Written by Online editor on . Posted in Innovation

For many years, Switzerland has been one of the most innovative and competitive business locations in Europe. The canton of Aargau's strong life sciences industry makes an especially significant contribution to Swiss innovativeness.

Switzerland – worldwide workforce leader in life sciences
The Swiss life sciences cluster stretches from Basel to Fricktal, a valley in the canton of Aargau. Over 900 life sciences companies are present in the region, which constitute about 40 percent of the world’s life sciences industry. Of the one million people living in the region, about one person out of ten is employed in the life sciences industry. Switzerland is the worldwide leader in workforce in the life sciences industry compared to the size of its population.

The Robot Revolution

Written by Patricia Cullen on . Posted in Innovation

With the shock of Brexit threatening job stability and redundancies in the UK, it is easy to overlook how production is evolving to incorporate more machines, programming and robots, which will, in turn, have a long-term, negative impact on employment. A ‘robot revolution’, expected to arrive in the next 20 years, will change the way in which the international economy operates, decreasing business costs and increasing social inequality, as machines and equipment handle everything from manual cleaning jobs to caring for the aged. But if technologies are able to do work traditionally done by humans, are employees going to become surplus to requirements?

Winds of Change Dompé: Excellence in Healthcare Innovation

Written by Online editor on . Posted in Innovation

The healthcare and pharmaceutical industry has been experiencing a period of rapid change over the last decade, from the growth of populations in the developing world to the impact of ageing and the arising of new and more targeted medical needs. As a result of these new challenges, the industry is seeing a boom in innovation, with biotechnology becoming increasingly important, alongside personalized treatments. Another area of growth is in rare and orphan disease treatments, a sector that has become increasingly important over the last few years.

Choosing the “playing field” has become an imperative for the pharmaceutical companies all over the world: from developing drugs that could offer a therapeutic response to widespread health needs, to using R&D with the aim of responding in a targeted manner to the needs of the individual through network-orientated research.

Made in Italy

Written by Patricia Cullen on . Posted in Innovation

Biotechnology is at the forefront of medical science, facilitating the future of healthcare, vis-a-vis the treatment of disease and long term health conditions, and the biotech sphere is growing in Europe. 

The North American pharmaceutical-biotech industry continues to return a strong capital investment profile, but the amount of project activity across this side of the pond can’t be ignored. While the global biotech boom weakened last year, 2015 has set a new record for the European biotech sector, making €6.26bn compared to €3.44bn in 2014. European countries are among the most innovative on the planet when it comes to drug development, and Europe is a world-class hub for new ideas and collaborative research with over 2,000 companies and more than 50,000 employees. In excess of €2bn is invested annually in R&D and there is growing recognition that Europe is home to high-quality, resourceful biotech start-ups. SME’s are already getting better funding, thanks to innovative, streamlined procedures for collaboration and applications for funding under Horizon 2020. With a financial plan of approximately €80b, the European Commission’s research and innovation programme, developing a high-value, globally competitive sector alongside the Bioeconomy Strategy and Action Plan for Europe, will help connect great people with great ideas, offering the opportunity to make great things happen. 

Get Connected with PrintFleet

Written by Jamie on . Posted in Innovation










PrintFleet supplies data to enable the automation of processes and high-value applications for the global imaging industry. It is a leader in the print management arena, being the first company to offer a rapid assessment tool, a comprehensive dealer hosted remote print monitoring application, and various professional development and training programmes. Managing over 3.5 billion pages monthly worldwide, PrintFleet offers unparalleled data collection, data integrity and back-end support within its family of print management software solutions, ranging from simple rapid assessment to advanced, independently hosted device management and automated supplies fulfilment. The company’s software, coupled with its award-winning sales, marketing and technical support programmes, allow dealers to build stronger customer relationships while evolving their overall corporate value.

1.Can you tell us a little about the history of PrintFleet and the products it offers?

PrintFleet was founded in 2003. Founder Brian Cosgrove, recognized that there was value in being able to determine which toners were in demand. From there, he recruited a dedicated team of developers to design a solution to capture, analyse and report key device metrics from multi-function print devices. This became the foundation for all of PrintFleet’s products and services. Today, we specialize in the development of data-driven device management and assessment solutions, as well as training, business development and support programs for dealers, distributers and manufacturers in the imaging industry. Our range of solutions vary from simple rapid assessment tools to complete remote monitoring and management of most print devices to end-to-end supply chain automation.

Uber Efficient

Written by Patricia Cullen on . Posted in Innovation

Want to book a flight to Barcelona by simply sending a text message? There’s an app for that. How about ordering from some of the best restaurants with the touch of a button? There’s also an app for that. Would you like to reserve a table in a pub without talking to a soul? Yes – there is an app for that too. 

In the not too distant future we may well be using a single, simple smartphone app to do all of the above, and more. Apps are revolutionising our social life, and the persistent growth of the on-demand sector, that focuses on the here and now and instant gratification, proves that consumers are attracted to start-ups promising to fulfil all their needs within seconds. That’s why businesses like Uber, the car service that operates in 53 countries, that don’t aspire to invent new products or goods, but instead focus on changing the way industries work, making our lives more convenient in the process, are doing so well.  The ability to act as middlemen in a market that matches people looking to buy a service with others who are providing it seems priceless. Siri, Apple’s voice-based virtual assistant, promised this practicality but never actually lived up to the hype. Back in 2011, Siri was meant to change the manner in which we communicated with our computers and phones. But that just didn't happen. 

Identical Response to Gluten in Most Children and Adults with Celiac Disease

Written by Bob Anderson, M.D., Ph.D., on . Posted in Innovation

CAMBRIDGE, Mass. — ImmusanT, Inc., a company focused on restoring tolerance to gluten and overcoming the need for gluten-free diet in patients with celiac disease, today announced the publication of an article online in the journal Gastroenterology that details new research comparing the T cell response to gluten in children and adults with c According to researchers, the recognition of gluten peptides by T cells in children with celiac disease is similar to that of adults, supporting the notion that peptide-based diagnostics and therapeutics currently under development by ImmusanT for adult patients may also be used for children. The international team who led the study included the company’s collaborators at the Walter and Eliza Hall Institute (WEHI) of Medical Research in Australia: Melinda Hardy, Ph.D., and head of celiac disease research, Jason Tye-Din, Ph.D. ImmusanT’s chief scientific officer, Bob Anderson, M.D., Ph.D., is a senior author of the recently published manuscript. 

Strategies to Meet Increased Global Demand for Animal Protein

Written by the Online Editor on . Posted in Innovation

With the global population projected to reach more than 9 billion by 2050, global demand for food will essentially double, which could significantly increase carbon dioxide and nitrogen levels in the environment and lead to the extinction of numerous species agricultural practices.

The National Research Council released a new report that found meeting the expected growth in global demand for animal protein in a way that is economically, environmentally and socially sustainable will require a greater investment in animal science research. The report identified research priorities and recommends that governments and the private sector increase their support for this research.


CEO Insight,
245 Shakespeare House, Shakespeare Road,
Tel: +44 (0) 20 7924 9908